National Health Investors, Inc.
NHI
$78.49
-$0.12-0.15%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 268.24M | 263.73M | 257.05M | 251.99M | 250.92M |
| Total Other Revenue | 82.36M | 79.89M | 78.54M | 77.86M | 76.09M |
| Total Revenue | 350.60M | 343.62M | 335.58M | 329.85M | 327.01M |
| Cost of Revenue | 10.52M | 12.30M | 11.63M | 13.53M | 12.95M |
| Gross Profit | 340.07M | 331.32M | 323.96M | 316.32M | 314.06M |
| SG&A Expenses | 26.35M | 24.17M | 21.79M | 21.03M | 20.48M |
| Depreciation & Amortization | 75.52M | 73.10M | 71.44M | 69.87M | 69.62M |
| Other Operating Expenses | 42.94M | 42.74M | 42.29M | 39.54M | 39.46M |
| Total Operating Expenses | 155.34M | 152.31M | 147.15M | 143.97M | 142.50M |
| Operating Income | 195.26M | 191.31M | 188.43M | 185.88M | 184.51M |
| Income Before Tax | 141.54M | 139.80M | 136.64M | 125.57M | 126.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 141.54 | 139.80 | 136.64 | 125.57 | 126.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.40M | 1.41M | 1.35M | 1.22M | 1.23M |
| Net Income | 142.93M | 141.20M | 137.99M | 126.79M | 127.60M |
| EBIT | 195.26M | 191.31M | 188.43M | 185.88M | 184.51M |
| EBITDA | 270.78M | 264.41M | 259.88M | 255.76M | 254.13M |
| EPS Basic | 3.15 | 3.17 | 3.14 | 2.92 | 2.94 |
| Normalized Basic EPS | 1.88 | 1.88 | 1.86 | 1.85 | 1.83 |
| EPS Diluted | 3.13 | 3.15 | 3.12 | 2.91 | 2.93 |
| Normalized Diluted EPS | 1.87 | 1.87 | 1.85 | 1.84 | 1.83 |
| Average Basic Shares Outstanding | 181.01M | 177.71M | 175.38M | 173.65M | 173.56M |
| Average Diluted Shares Outstanding | 182.12M | 178.86M | 176.41M | 174.36M | 173.77M |
| Dividend Per Share | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Payout Ratio | 112.99% | 112.29% | 113.43% | 123.29% | 122.49% |